Please select the option that best describes you:
What is your preferred P2Y12 inhibitor to use upstream of STEMI cases, if you decide to administer an agent before proceeding to the cath lab?
Or is your practice pattern to defer upstream administration of a P2Y12 inhibitor altogether?